Medieval warhorses no bigger than modern-day ponies, research finds
Shire takeover in balance after $2.4 billion sale to French
Market Report: Shire higher as investors rethink $32bn Baxalta deal
Shire on the slide as revived $32 billion Baxalta bid fails to impress
Market Report: Shire slips as pursuit of Baxalta fails to impress
Burberry is making a £50 million bet on Yorkshire
Pfizer circles Botox-maker Allergan for possible $300 billion merger
Market Report: Shire’s shares dip as wait for US drug approval goes on
